Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Dec 19, 2025 (10 months ago)

Wegovy (semaglutide)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: Hair was found in a prefilled syringe

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Affected NDC 0169-4505-14

Compare with the code on your package — it is the most precise check available.

Drug: Semaglutide

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Wegovy
semaglutide
NDC 00169-4505
.5 mg/.5mL Injection, Solution
Subcutaneous
Novo Nordisk Pharmaceutical Industries, LP Rx
Recalling firm
Novo Nordisk Inc.
NDC code
0169-4505-14
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0244-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Semaglutide recalls

See all
Class II · Moderate risk

SEMAGLUTIDE 20mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-724-04 D-0757-2026
Class II · Moderate risk

SEMAGLUTIDE 10mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-722-02 D-0756-2026
Class II · Moderate risk

SEMAGLUTIDE 7.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-721-01 D-0755-2026
Class II · Moderate risk

SEMAGLUTIDE 5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-712-03 D-0754-2026
Class II · Moderate risk

SEMAGLUTIDE 2.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-711-02 D-0753-2026

Other recalls by Novo Nordisk Inc.

All 2025 recalls
Class I · High risk

Xultophy 100/3.6

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-2911-90 D-0623-2021
Class II · Moderate risk

ViCTOZA (liraglutide)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-4060-90 D-0622-2021
Class I · High risk

TRESIBA FlexTouch

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-2550-90 D-0621-2021